taVNS on the Inpatient Psychiatric Unit

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

March 24, 2024

Study Completion Date

March 24, 2024

Conditions
Depression, Anxiety
Interventions
DEVICE

transcutaneous auricular neurostimulation

All transcutaneous auricular neurostimulation procedures will be conducted using the Spark Biomedical device. We will use stimulation parameters similar to ongoing taVNS work (25Hz, 500us pulse width) and a duty cycle of 1 minute on, 30 s off, repeated for 30 minutes. taVNS sessions are considered complete after 30minutes. Subsequent taVNS sessions may be repeated no less than 30minutes after prior session completion. All subjects will begin with taVNS administered to the left auricle, however, if they begin to experience any irritation or discomfort of the left ear, study team staff will offer subjects the option to stop stimulation or switch stimulation to the right auricle.

Trial Locations (1)

29425

Medical University of South Carolina Institute of Psychiatry, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER